Is National Research Corp (NRC) overvalued? · P/E 46, rev $143.1M
National Research Corp (NRC) is a health information services company listed on NASDAQ.
This page asks whether National Research Corp (NRC) looks expensive on cached numbers — not a short thesis.
Latest reported NRC revenue for 2024-12-31 was $143.1M. Net income was $24.8M. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
NRC currently screens at market cap $400.0M and trailing P/E 45.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NRC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NRC stock page for the full model, not this heading.
Not investment advice.